Advertisement
Screener

PHARMASSET INC Stock-Based Compensation

PHARMASSET INC Stock-Based Compensation

PHARMASSET INC reported Stock-Based Compensation of $7.81 million for the 12-month period ending 2011-09-30, per its 10-K filed 2011-11-14.

Discontinued › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2011-11-14

  • PHARMASSET INC share-based payment arrangement, noncash expense for the quarter ending 2011-09-30 was $2.07M, a 64.36% increase year-over-year.
  • PHARMASSET INC share-based payment arrangement, noncash expense for the quarter ending 2010-09-30 was $1.26M.
  • PHARMASSET INC share-based payment arrangement, noncash expense for fiscal 2011 was $7.81M, a 40.77% increase from fiscal 2010.
  • PHARMASSET INC share-based payment arrangement, noncash expense for fiscal 2010 was $5.55M, a 21.66% increase from fiscal 2009.
  • PHARMASSET INC share-based payment arrangement, noncash expense for fiscal 2009 was $4.56M.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 12 month
2011-09-30$2.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2011-11-14
$7.81M
10-K · filed 2011-11-14
2011-06-30$5.75M
10-Q · filed 2011-08-09
2010-09-30$1.26M
derived: 10-K 12 month − 10-Q 9 month · filed 2011-11-14
$5.55M
10-K · filed 2011-11-14
2010-06-30$4.29M
10-Q · filed 2011-08-09
2009-09-30$4.56M
10-K · filed 2011-11-14